Endocrine Consequences of Long-Term Intrathecal Administration of Opioids
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Intrathecal administration of opioids is a very efficient tool in the long-term control of intractable nonmalignant pain. However, despite the well known role of opioids in endocrine regulation, few data are available about possible effects on hypothalamic-pituitary function during this treatment. Seventy-three patients (29 men and 44 women; mean age, 49.2 ± 11.7 yr) receiving opioids intrathecally for nonmalignant pain were enrolled for extensive endocrine investigation. At the time of hormonal determination, the mean duration of opioid treatment was 26.6 ± 16.3 months; the mean daily dose of morphine was 4.8 ± 3.2 mg. The control group consisted of 20 patients (11 men and 9 women; mean age, 54.2 ± 14.0 yr) with a comparable pain syndrome but not treated with opioids. Decreased libido or impotency was present in 23 of 24 men receiving opioids. The serum testosterone level was below 9 nmol/L in 25 of 29 men and was significantly lower than that in the control group (P < 0.001). The free androgen index was below normal in 18 of 29 men and was significantly lower than that in the control group (P < 0.001). The serum LH level was less than 2 U/L in 20 of 29 men and was significantly lower than that in the control group (P < 0.001). Serum FSH was comparable in both groups. Decreased libido was present in 22 of 32 women receiving opioids. All 21 premenopausal females developed either amenorrhea or an irregular menstrual cycle, with ovulation in only 1. Serum LH, estradiol, and progesterone levels were lower in the opioid group. In all 18 postmenopausal females significantly decreased serum LH (P < 0.001) and FSH (P = 0.012) levels were found. The 24-h urinary free cortisol excretion was below 20 μg/day in 14 of 71 opioid patients and was significantly lower than that in the control group (P = 0.003). The peak cortisol response to insulin-induced hypoglycemia was below 180 μg/L in 9 of 61 opioid patients and was significantly lower than that in the nonopioid group (P = 0.002). The insulin-like growth factor I sd score was below −2 sd in 12 of 73 opioid patients and was significantly lower than that in the control group (P = 0.002). The peak GH response to hypoglycemia was below 3 μg/L in 9 of 62 subjects and was significantly lower than that in the control group (P = 0.010). Thyroid function tests and PRL levels were considered normal. No metabolic disturbances were recorded, apart from significantly decreased high density lipoprotein cholesterol levels (P = 0.041) and elevated total/high density lipoprotein cholesterol ratio (P = 0.008) in the opioid group compared to the control group. Supplementation with gonadal steroids improved sexual function in most patients. In conclusion, of all patients receiving intrathecal opioids, the large majority of men and all women developed hypogonadotropic hypogonadism, about 15% developed central hypocorticism, and about 15% developed GH deficiency. These findings suggest that further investigations are required to determine the need for systematic endocrine work-up in these patients and the necessity for substitutive therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A landmark study published 3 years later, investigating the effects of intrathecal opioids using the insulin tolerance test (ITT) (the gold standard for the diagnosis of secondary adrenal insufficiency), showed that 15% (9/61) of the patients on intrathecal opioids for nonmalignant pain had secondary adrenal insufficiency (74).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“These results suggest that up to 17% of the patients treated with intrathecal opioids may develop GH deficiency (74).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“Twelve opioid-treated patients (17%) had an IGF-I SD score below -2 SD, as opposed to no such case in the control group.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“Nine opioid-treated patients (15%) had a peak GH value consistent with severe GH deficiency (below 3 mcg/L), a finding not demonstrated in any control patient.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“The opioid-treated group had lower mean serum IGF-I (138.5 mcg/L ± 64.1) in comparison to the controls (162.0mcg/L ± 55.3; P = .045),as well as lower IGF-I SD score (-0.53 ± 1.45 and 0.57 ± 1.00; P = .002).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A quantitative approach to perceived health status: a validation study
Hunt, S. M., McKenna, S. P., McEwen, J., Backett, E. M., Williams, J., & Papp, E. (1980) · Journal of Epidemiology and Community Health · doi:10.1136/jech.34.4.281 · Cited by 924
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Side effects of intrathecal and epidural opioids
Chaney, M. A. (1995) · Canadian Journal of Anaesthesia · doi:10.1007/bf03011037 · Cited by 562
The Diagnosis of Growth Hormone Deficiency in Adults
Ho, K. K. Y., & Hoffman, D. M. (1997) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.6.suppl10_35 · Cited by 428
Diagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
The growth hormone deficiency syndrome in adults
Cuneo, R. C., Salomon, F., McGauley, G. A., & Sönksen, P. H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02347.x · Cited by 375
Winkelmüller, M., & Winkelmüller, W. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.85.3.0458 · Cited by 333
Intraspinal morphine for chronic pain: A retrospective, multicenter study
Paice, J. A., Penn, R. D., & Shott, S. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00099-2 · Cited by 302
The endocrinology of the opiates and opioid peptides
Morley, J. E. (1981) · Metabolism · doi:10.1016/0026-0495(81)90172-4 · Cited by 283
The Use of Opioids for the Treatment of Chronic Pain*
&NA; (1997) · The Clinical Journal of Pain · doi:10.1097/00002508-199703000-00003 · Cited by 208
Research works printed but not linked: 1
- Gijbels, 1998, Neuromodulation of pain. A consensus statement of the European Federation of IASP Chapters (EFIC)., Eur J Pain, 2, 203
Cited by
Opioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
Kalso, E., Edwards, J. E., Moore, A. R., & McQuay, H. J. (2004) · Pain · doi:10.1016/j.pain.2004.09.019 · Cited by 1,216
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 959
(2005) · doi:10.1016/j.ucl.2005.08.007 · Cited by 759
Long-term opioid management for chronic noncancer pain
Noble, M., Treadwell, J. R., Tregear, S. J., Coates, V. H., Wiffen, P. J., Akafomo, C., Schoelles, K. M., & Chou, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006605.pub2 · Cited by 735
Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia
Walker, E., Mittal, V., & Tessner, K. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.4.022007.141248 · Cited by 615
Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial
Raja, S. N., Haythornthwaite, J. A., Pappagallo, M., Clark, M. R., Travison, T. G., Sabeen, S., Royall, R. M., & Max, M. B. (2002) · Neurology · doi:10.1212/wnl.59.7.1015 · Cited by 593
Sex differences in pain and analgesia: the role of gonadal hormones
Craft, R. M., Mogil, J. S., & Aloisi, A. M. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2004.01.003 · Cited by 570
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Therapeutic Use, Abuse, and Nonmedical Use of Opioids: A Ten-Year Perspective
Manchikanti, L. (2010) · Pain Physician · doi:10.36076/ppj.2010/13/401 · Cited by 545
Pharmacology of Penile Erection
Andersson, K.-E. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01503-5 · Cited by 528
van Winkel, R., Stefanis, N. C., & Myin-Germeys, I. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn101 · Cited by 489
Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
Gratzke, C., Angulo, J., Chitaley, K., Dai, Y.-T., Kim, N. N., Paick, J.-S., Simonsen, U., Ückert, S., Wespes, E., Andersson, K. E., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01624.x · Cited by 464
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s5 · Cited by 436
Sex-Based Differences in Pain Perception and Treatment
Paller, C. J., Campbell, C. M., Edwards, R. R., & Dobs, A. S. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2008.00558.x · Cited by 395
Reactive oxygen species and male reproductive hormones
Darbandi, M., Darbandi, S., Agarwal, A., Sengupta, P., Durairajanayagam, D., Henkel, R., & Sadeghi, M. R. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0406-2 · Cited by 379
Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction
Andersson, K.-E. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004515 · Cited by 392
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Clinical Management of Congenital Hypogonadotropic Hypogonadism
Young, J., Xu, C., Papadakis, G. E., Acierno, J. S., Maione, L., Hietamäki, J., Raivio, T., & Pitteloud, N. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00116 · Cited by 396
Predicting Opioid Misuse by Chronic Pain Patients: A Systematic Review and Literature Synthesis
Turk, D. C., Swanson, K. S., & Gatchel, R. J. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816b1070 · Cited by 376
Moore, R. A., & McQuay, H. J. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1782 · Cited by 377
Van Uum, S. H. M., Sauvé, B., Fraser, L. A., Morley-Forster, P., Paul, T. L., & Koren, G. (2008) · Stress · doi:10.1080/10253890801887388 · Cited by 332
The impact of opioids on the endocrine system
Katz, N., & Mazer, N. A. (2009) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181850df6 · Cited by 307
Opioid Guidelines in the Management of Chronic Non-Cancer Pain
Manchikanti, L. (2006) · Pain Physician · doi:10.36076/ppj.2006/9/2 · Cited by 277
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263
Hassenbusch, S. J., Portenoy, R. K., Cousins, M. J., Buchser, E., Deer, T. R., Pen, S. L. D., Eisenach, J. C., Follett, K. A., Hildebrand, K. R., Krames, E. S., et al. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.03.001 · Cited by 226
The insults of illicit drug use on male fertility
Fronczak, C. M., Kim, E. D., & Barqawi, A. B. (2012) · Journal of Andrology · doi:10.2164/jandrol.110.011874 · Cited by 217
Adverse Effects Associated with Non-opioid and Opioid Treatment in Patients with Chronic Pain
Labianca, R., Sarzi-Puttini, P., Zuccaro, S. M., Cherubino, P., Vellucci, R., & Fornasari, D. (2012) · Clinical Drug Investigation · doi:10.2165/11630080-000000000-00000 · Cited by 201
Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids
Rajagopal, A., Vassilopoulou‐Sellin, R., Palmer, J. L., Kaur, G., & Bruera, E. (2004) · Cancer · doi:10.1002/cncr.20028 · Cited by 206
Opioid Analgesia: Perspectives on Right Use and Utility
Ballantyne, J. C. (2007) · Pain Physician · doi:10.36076/ppj.2007/10/479 · Cited by 142
Chapman, C. R., Lipschitz, D. L., Angst, M. S., Chou, R., Denisco, R. C., Donaldson, G. W., Fine, P. G., Foley, K. M., Gallagher, R. M., Gilson, A. M., et al. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.02.019 · Cited by 172
Deer, T. R., Pope, J. E., Hayek, S. M., Lamer, T. J., Veizi, I. E., Erdek, M., Wallace, M. S., Grider, J. S., Levy, R. M., Prager, J., et al. (2017) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/ner.12579 · Cited by 174
The Effect of Opioid Therapy on Endocrine Function
Brennan, M. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.001 · Cited by 166
Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options
Deer, T. R., Pope, J. E., Hanes, M. C., & McDowell, G. C. (2019) · Pain Medicine · doi:10.1093/pm/pny132 · Cited by 153
Opioid use for noncancer pain and risk of myocardial infarction amongst adults
Li, L., Setoguchi, S., Cabral, H., & Jick, S. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12035 · Cited by 156
Best Practices for Intrathecal Drug Delivery for Pain
Prager, J. P., Deer, T. R., Levy, R. M., Bruel, B. M., Buchser, E., Caraway, D. L., Cousins, M. J., Jacobs, M. S., McGlothlen, G. L., Rauck, R. L., et al. (2014) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12146 · Cited by 156
Neuroendocrine Causes of Amenorrhea—An Update
Fourman, L. T., & Fazeli, P. K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3344 · Cited by 145
Opioids and endocrine dysfunction
Seyfried, O., & Hester, J. (2012) · British Journal of Pain · doi:10.1177/2049463712438299 · Cited by 160
Turner, J. A., Sears, J. M., & Loeser, J. D. (2007) · Clinical Journal of Pain · doi:10.1097/01.ajp.0000210955.93878.44 · Cited by 148
Sex hormone activity in alcohol addiction: Integrating organizational and activational effects
Lenz, B., Müller, C. P., Stoessel, C., Sperling, W., Biermann, T., Hillemacher, T., Bleich, S., & Kornhuber, J. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.11.001 · Cited by 135
Evidence for a key role of steroids in the modulation of pain
Mensah‐Nyagan, A. G., Meyer, L., Schaeffer, V., Kibaly, C., & Patte‐Mensah, C. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.004 · Cited by 155
Rhodin, A., Stridsberg, M., & Gordh, T. (2010) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181d1059d · Cited by 142
Daniell, H. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.04.011 · Cited by 144
Opioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139
The Physiologic Effects of Pain on the Endocrine System
Tennant, F. S. (2013) · Pain and Therapy · doi:10.1007/s40122-013-0015-x · Cited by 160
Ammon, S., Mayer, P. E., Riechert, U., Tischmeyer, H., & Höllt, V. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00057-3 · Cited by 139
Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency
Daniell, H. W., Lentz, R., & Mazer, N. A. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.10.009 · Cited by 135
Drug-Related Side Effects of Long-term Intrathecal Morphine Therapy
Ruan, X. (2007) · Pain Physician · doi:10.36076/ppj.2007/10/357 · Cited by 135
Raphael, J. H., Ahmedzai, S. H., Hester, J., Urch, C., Barrie, J., Williams, J. E., Farquhar-Smith, P. W., Fallon, M., Hoskin, P., Robb, K. A., et al. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00840.x · Cited by 145
Opioid-Induced Androgen Deficiency (OPIAD)
Elliott, J. A. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es145 · Cited by 129
Sex Hormone Suppression by Intrathecal Opioids: A Prospective Study
Roberts, L. J., Finch, P. M., Pullan, P. T., Bhagat, C. I., & Price, L. M. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200205000-00002 · Cited by 128
Pain and Sex Hormones: A Review of Current Understanding
Maurer, A. J., Lissounov, A., Knezevic, I., Candido, K. D., & Knezevic, N. N. (2016) · Pain Management · doi:10.2217/pmt-2015-0002 · Cited by 112
Morphine-induced Changes of Gene Expression in the Brain
Ammon-Treiber, S., & Höllt, V. (2005) · Addiction Biology · doi:10.1080/13556210412331308994 · Cited by 124
Basaria, S., Travison, T. G., Alford, D., Knapp, P. E., Teeter, K., Cahalan, C., Eder, R., Lakshman, K., Bachman, E., Mensing, G., et al. (2015) · Pain · doi:10.1097/01.j.pain.0000460308.86819.aa · Cited by 125
Lifestyle, Environment, and Male Reproductive Health
Barazani, Y., Katz, B., Nagler, H. M., & Stember, D. S. (2013) · Urologic Clinics of North America · doi:10.1016/j.ucl.2013.08.017 · Cited by 125
Testosterone suppression in opioid users: A systematic review and meta-analysis
Bawor, M., Bami, H., Dennis, B. B., Plater, C., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Steiner, M., Anglin, R., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.038 · Cited by 123
Deer, T. R., Levy, R. M., Prager, J. P., Buchser, E., Burton, A., Caraway, D. L., Cousins, M. J., Andrés, J. A. D., Diwan, S. A., Erdek, M. A., et al. (2012) · Neuromodulation Technology at the Neural Interface · doi:10.1111/j.1525-1403.2012.00486.x · Cited by 121
Neuropathic pain and SCI: Identification and treatment strategies in the 21st century
Hatch, M. N., Cushing, T. R., Carlson, G. D., & Chang, E. Y. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.11.018 · Cited by 124
Impact of the opioid system on the reproductive axis
Böttcher, B., Seeber, B., Leyendecker, G., & Wildt, L. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.009 · Cited by 115
Akhigbe, R. E., & Ajayi, A. F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0224052 · Cited by 127
Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women
Fraser, L.-A., Morrison, D., Morley-Forster, P., Paul, T., Tokmakejian, S., Larry Nicholson, R., Bureau, Y., Friedman, T., & Uum, S. H. M. V. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1076715 · Cited by 112
Strasser, F., Palmer, J. L., Schover, L. R., Yusuf, S. W., Pisters, K., Vassilopoulou‐Sellin, R., DeGracia, B., Willey, J. S., & Bruera, E. (2006) · Cancer · doi:10.1002/cncr.22339 · Cited by 112
Lanfranco, F., Bonelli, L., Baldi, M., Me, E., Broglio, F., & Ghigo, E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0049 · Cited by 112
Opioid use disorder and treatment: challenges and opportunities
Hoffman, K. A., Terashima, J. P., & McCarty, D. W. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4751-4 · Cited by 112
Endocrine consequences of opioid therapy
Aloisi, A. M., Aurilio, C., Bachiocco, V., Biasi, G., Fiorenzani, P., Pace, M. C., Paci, V., Pari, G., Passavanti, G., Ravaioli, L., et al. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.013 · Cited by 107
Sanga, P., Katz, N., Polverejan, E., Wang, S., Kelly, K., Haeussler, J., & Thipphawong, J. (2013) · Pain · doi:10.1016/j.pain.2013.05.051 · Cited by 78
Li, L., Setoguchi, S., Cabral, H., & Jick, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt013 · Cited by 100
Outcome of intrathecal opioids in chronic non‐cancer pain
Roberts, L. J., Finch, P. M., Goucke, R. C., & Price, L. M. (2001) · European Journal of Pain · doi:10.1053/eujp.2001.0255 · Cited by 105
Implantable intrathecal pumps for chronic pain: highlights and updates.
Knight, K. H., Brand, F., Mchaourab, A. S., & Veneziano, G. (2007) · PubMed · Cited by 103
Medical and Psychological Risks and Consequences of Long-Term Opioid Therapy in Women
Darnall, B. D., Stacey, B. R., & Chou, R. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01467.x · Cited by 109
Prescribed opioid analgesic use developments in three Nordic countries, 2006–2017
Muller, A. E., Clausen, T., Sjøgren, P., Odsbu, I., & Skurtveit, S. O. (2019) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2018-0307 · Cited by 108
The physiology of male reproduction: Impact of drugs and their abuse on male fertility
Ajayi, A. F., & Akhigbe, R. E. (2020) · Andrologia · doi:10.1111/and.13672 · Cited by 107
Age of Menopause and Menopausal Symptoms in HIV-Infected Women
Fantry, L. E., Zhan, M., Taylor, G. H., Sill, A. M., & Flaws, J. A. (2005) · AIDS Patient Care and STDs · doi:10.1089/apc.2005.19.703 · Cited by 100
Hypogonadism in male patients with cancer
Garcia, J. M., Li, H., Mann, D., Epner, D., Hayes, T. G., Marcelli, M., & Cunningham, G. R. (2006) · Cancer · doi:10.1002/cncr.21889 · Cited by 100
Hamza, M., Doleys, D. M., Wells, M., Weisbein, J. S., Hoff, J., Martin, M., Soteropoulos, C., Barreto, J., Deschner, S., & Ketchum, J. M. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01451.x · Cited by 104
The many faces of testosterone
Bain, J. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1417 · Cited by 113
Belverud, S. A., Mogilner, A. Y., & Schulder, M. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.10.070 · Cited by 98
Deer, T. R., Hayek, S. M., Pope, J. E., Lamer, T. J., Hamza, M., Grider, J. S., Rosen, S. M., Narouze, S., Perruchoud, C., Thomson, S., et al. (2017) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12543 · Cited by 94
ACOEM Practice Guidelines: Opioids for Treatment of Acute, Subacute, Chronic, and Postoperative Pain
Hegmann, K. T., Weiss, M., Bowden, K., Branco, F., DuBrueler, K., Els, C., Mandel, S., McKinney, D. W., Miguel, R. V., Mueller, K. L., et al. (2014) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000352 · Cited by 103
Methadone Maintenance and Male Sexual Dysfunction
Brown, R., Balousek, S. L., Mundt, M. P., & Fleming, M. (2005) · Journal of Addictive Diseases · doi:10.1300/j069v24n02_08 · Cited by 92
Reddy, R. G., Aung, T., Karavitaki, N., & Wass, J. A. H. (2010) · BMJ · doi:10.1136/bmj.c4462 · Cited by 90
Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy
Rajagopal, A., Vassilopoulou‐Sellin, R., Palmer, J. L., Kaur, G., & Bruera, E. D. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00331-2 · Cited by 95
Effects of gabapentin on morphine consumption and pain in severely burned patients
Cuignet, O., Pirson, J., Soudon, O., & Zizi, M. (2006) · Burns · doi:10.1016/j.burns.2006.04.020 · Cited by 89
Substance Abuse and Male Hypogonadism
Duca, Y., Aversa, A., Condorelli, R. A., Calogero, A. E., & Vignera, S. L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050732 · Cited by 94
Testosterone deficiency in non-cancer opioid-treated patients
Coluzzi, F., Billeci, D., Maggi, M., & Corona, G. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0964-3 · Cited by 81
Opioid-Induced Adrenal Insufficiency
Donegan, D., & Bancos, I. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.010 · Cited by 78
23. Pain in Patients with Cancer
Vissers, K. C. P., Besse, K., Wagemans, M. F. M., Zuurmond, W. W. A., Giezeman, M. J. M. M., Lataster, A., Mekhail, N. A., Burton, A. W., van Kleef, M., & Huygen, F. J. P. M. (2011) · Pain Practice · doi:10.1111/j.1533-2500.2011.00473.x · Cited by 81
Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy
Sehgal, N., Colson, J., & Smith, H. S. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.846517 · Cited by 79
Peeters, B., Meersseman, P., Vander Perre, S., Wouters, P. J., Debaveye, Y., Langouche, L., & Van den Berghe, G. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5427-y · Cited by 48
Clark, M. J., Schopp, L. H., Mazurek, M. O., Zaniletti, I., Lammy, A. B., Martin, T., Thomas, F. P., & Acuff, M. E. (2008) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3181837f4f · Cited by 81
Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
Aloisi, A., Ceccarelli, I., Carlucci, M., Suman, A., Sindaco, G., Mameli, S., Paci, V., Ravaioli, L., Passavanti, G., Bachiocco, V., et al. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-26 · Cited by 77
Opioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Opioid-induced endocrinopathy.
Colameco, S., & Coren, J. S. (2009) · PubMed · Cited by 92
Intrathecal drug therapy for long-term pain management
Ghafoor, V. L., Epshteyn, M., Carlson, G. H., Terhaar, D. M., Charry, O., & Phelps, P. K. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060204 · Cited by 75
Atli, A., Theodore, B. R., Turk, D. C., & Loeser, J. D. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00876.x · Cited by 75
Chronic Pain Following Treatment for Cancer: The Role of Opioids
Ballantyne, J. C. (2003) · The Oncologist · doi:10.1634/theoncologist.8-6-567 · Cited by 80
Aloisi, A. M., Pari, G., Ceccarelli, I., Vecchi, I., Ietta, F., Lodi, L., & Paulesu, L. (2005) · Pain · doi:10.1016/j.pain.2005.02.019 · Cited by 75
Intrathecal Hydromorphone for Chronic Nonmalignant Pain: A Retrospective Study
Anderson, V. C., Cooke, B., & Burchiel, K. J. (2001) · Pain Medicine · doi:10.1046/j.1526-4637.2001.01052.x · Cited by 72
Opioid Related Endocrinopathy: Table 1
Gudin, J. A., Laitman, A. P., & Nalamachu, S. R. (2015) · Pain Medicine · doi:10.1111/pme.12926 · Cited by 74
Chronic pain therapy and hypothalamic-pituitary-adrenal axis impairment
Aloisi, A. M., Buonocore, M., Merlo, L., Galandra, C., Sotgiu, A., Bacchella, L., Ungaretti, M., Demartini, L., & Bonezzi, C. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.12.017 · Cited by 72
Metadata
- Authors
- Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K.
- Affiliations
- Antwerp University Hospital (BE)
- Maria Middelares Hospital St. Niklaas (J.-P.V.B.), B-2650 Edegem, Belgium
- ZNA Middelheim Hospital (BE)
- Department of Neurosurgery, University Hospital Antwerp (J.V., T.V.H.), B-2650 Edegem, Belgium
- Department of Endocrinology, University Hospital Antwerp (R.A., K.V.A.), B-2650 Edegem, Belgium
- ORCID
- Smet, Mike
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-06-01
- Volume
- 85
- Issue
- 6
- Pages
- 2215-2222
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2135470636
- Cited by
- 491
- References
- 33
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 16 · 2023: 14 · 2022: 22 · 2021: 20 · 2020: 17 · 2019: 23 · 2018: 23 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 20 · 2013: 26 · 2012: 32
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- intrathecal opioids, morphine, hypothalamic-pituitary function, testosterone, free androgen index, luteinizing hormone, follicle-stimulating hormone, amenorrhea, menstrual cycle, sexual desire, erectile dysfunction, urinary free cortisol, insulin-induced hypoglycemia, cortisol response, hypothalamic-pituitary-adrenal axis, chronic non-cancer pain
- MeSH terms
- Adult, Aged, Aged, 80 and over, Amenorrhea, Analgesics, Opioid, Androgens, Blood Pressure, Hydromorphone, Estradiol, Female, Follicle Stimulating Hormone, Hormones, Humans, Hydrocortisone, Erectile Dysfunction, Injections, Spinal, Luteinizing Hormone, Libido, Male, Middle Aged, Morphine, Pain, Intractable, Intractable Pain, Progesterone, Reference Values, Retrospective Studies, Sex Hormone-Binding Globulin, Premenopause, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.